DJDaozhong Jin

Daozhong Jin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daozhong Jin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Hong Chen

    Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

    2 shared publications
  • Hui-Lin Pan

    Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

    2 shared publications
  • Shao-Rui Chen

    Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

    2 shared publications
  • Yuying Huang

    Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

    2 shared publications
  • Bing Xue

    Department of Basic Medical Science, School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA

    1 shared publication
  • John Q. Wang

    Department of Biomedical Sciences, School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA; Department of Anesthesiology, School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA

    1 shared publication

Latest Publications

  • BRAF recruitment to spinal sensory synapses promotes neuropathic pain by potentiating transsynaptic NMDA receptor activity

    by Daozhong Jin, Hong Chen, Yuying Huang, Shao-Rui Chen, Hui-Lin Pan

    Sustained hyperactivity of synaptic NMDA receptors (NMDARs) in the spinal dorsal horn is a hallmark of chronic neuropathic pain. Here, we identified the kinase BRAF as a critical regulator of this process. Spinal nerve injury in rats induced the translocation of BRAF from the dorsal root ganglion (DRG) to spinal cord synaptosomes, which was associated with enhanced phosphorylation of the downstream kinases MEK and ERK. In addition, spinal cord injury increased the interaction between NMDARs and BRAF/MEK/ERK in spinal cord samples from rats and humans. Pharmacological inhibition or genetic ablation of BRAF in mouse DRG neurons reversed nerve injury–induced NMDAR phosphorylation, synaptic trafficking, and presynaptic and postsynaptic hyperactivity in the spinal dorsal horn. Furthermore, whereas pain hypersensitivity persisted in wild-type mice after nerve injury, it was transient and less severe in mice that either lacked BRAF in DRG neurons or were treated with BRAF pathway inhibitors. Conversely, expressing a constitutively active BRAF mutant in DRG neurons induced sustained nociceptive hypersensitivity, which was blocked by NMDAR antagonists, gabapentin, or an α2δ-1 C-terminal-interfering peptide. This was accompanied by increased NMDAR phosphorylation and enhanced pre- and postsynaptic activity in the spinal cord. These findings reveal that BRAF in sensory neurons promotes neuropathic pain by enhancing NMDAR phosphorylation and transsynaptic hyperactivity and suggest that BRAF inhibitors might be repurposed to treat neuropathic pain.

  • Gα q signaling in primary sensory neurons shifts opioid analgesia to NMDA receptor–driven tolerance and hyperalgesia

    by Daozhong Jin, Hong Chen, Meng-Hua Zhou, Yuying Huang, Shao-Rui Chen, Hui-Lin Pan

    Opioids relieve pain by activating μ-opioid receptors (MORs), which inhibit communication between pain-sensing neurons (nociceptors) and the spinal cord. However, prolonged opioid use can paradoxically lead to increased pain sensitivity (hyperalgesia) and reduced analgesic efficacy (tolerance), partly because of the activation of NMDA-type glutamate receptors (NMDARs) at the central terminals of primary sensory neurons in the spinal cord. Here, we identified a critical role for the G protein Gα q in this paradox. Pharmacological inhibition of Gα q in rats reversed morphine-induced increases in NMDAR phosphorylation, synaptic trafficking, and activity at sensory neuron terminals and reduced morphine-induced excitatory nociceptive input to spinal dorsal horn neurons. Morphine enhanced Gα q coupling specifically to metabotropic glutamate receptor 5 (mGluR5) dimers in the spinal cord. Furthermore, targeted knockdown of Gα q in dorsal root ganglion neurons in mice normalized NMDAR-related changes and prevented NMDAR-mediated synaptic potentiation triggered by MOR activation. In addition, either pharmacological or genetic disruption of Gα q signaling enhanced morphine’s analgesic effects while reducing hyperalgesia and tolerance. These findings reveal that Gα q signaling contributes to opioid-induced NMDAR hyperactivity at nociceptor central terminals by promoting MOR-mGluR5 cross-talk. Targeting this pathway may improve the safety and efficacy of opioid-based pain management.